Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT00040391

Public ClinicalTrials.gov record NCT00040391. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Open-label, Controlled, Dose-elevation, Multicenter Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer

Study identification

NCT ID
NCT00040391
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celgene Corporation
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • 5-fluorouracil Drug
  • Investigational drug Drug
  • Irinotecan Drug
  • Leucovorin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2002
Primary completion
Not listed
Completion
Not listed
Last update posted
Nov 30, 2016

Started 2002

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Research Center Little Rock Arkansas 72205
Research Center Anaheim California 92801
Research Center Concord California 94520
Research Center Gilroy California 95020
Research Center Los Angeles California 90057
Research Center Jacksonville Florida 32207
Research Center New Port Richey Florida 34652
Research Center New Orleans Louisiana 70115
Research Center Scarborough Maine 04074-9308
Research Center Pittsfield Massachusetts 01201
Research Center East Lansing Michigan 48824
Research Center Saint Joseph Michigan 49085
Research Center Minneapolis Minnesota 55455
Research Center Saint Joseph Missouri 64507
Research Center Las Vegas Nevada 89106
Research Center East Setauket New York 11733
Research Center Northport New York 11768-2364
Research Center Burlington North Carolina 27216
Research Center Greenville North Carolina 27834
Research Center Zanesville Ohio 43701
Research Center Lancaster Pennsylvania 17605
Research Center Philadelphia Pennsylvania 19140-5189
Research Center Charleston South Carolina 29403
Research Center Charleston South Carolina 29406
Research Center Germantown Tennessee 38138
Research Center Dallas Texas 75230
Research Center Madison Wisconsin 53792-2454
Research Center Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00040391, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 30, 2016 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00040391 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →